- Home
- CCRN vs SVRA Comparison
CCRN vs SVRA Comparison
Compare CCRN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- SVRA
- Stock Information
- Founded
- CCRN 1986
- SVRA 2007
- Country
- CCRN United States
- SVRA United States
- Employees
- CCRN N/A
- SVRA N/A
- Industry
- CCRN Professional Services
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CCRN Consumer Discretionary
- SVRA Health Care
- Exchange
- CCRN Nasdaq
- SVRA Nasdaq
- Market Cap
- CCRN 452.6M
- SVRA 505.8M
- IPO Year
- CCRN N/A
- SVRA N/A
- Fundamental
- Price
- CCRN $13.99
- SVRA $2.92
- Analyst Decision
- CCRN Buy
- SVRA Buy
- Analyst Count
- CCRN 4
- SVRA 6
- Target Price
- CCRN $18.41
- SVRA $8.83
- AVG Volume (30 Days)
- CCRN 236.7K
- SVRA 598.8K
- Earning Date
- CCRN 05-07-2025
- SVRA 05-16-2025
- Dividend Yield
- CCRN N/A
- SVRA N/A
- EPS Growth
- CCRN N/A
- SVRA N/A
- EPS
- CCRN N/A
- SVRA N/A
- Revenue
- CCRN $1,258,238,000.00
- SVRA N/A
- Revenue This Year
- CCRN N/A
- SVRA N/A
- Revenue Next Year
- CCRN $4.50
- SVRA N/A
- P/E Ratio
- CCRN N/A
- SVRA N/A
- Revenue Growth
- CCRN N/A
- SVRA N/A
- 52 Week Low
- CCRN $9.58
- SVRA $2.26
- 52 Week High
- CCRN $18.50
- SVRA $5.31
- Technical
- Relative Strength Index (RSI)
- CCRN 40.64
- SVRA 56.79
- Support Level
- CCRN $13.50
- SVRA $2.81
- Resistance Level
- CCRN $13.97
- SVRA $3.56
- Average True Range (ATR)
- CCRN 0.26
- SVRA 0.18
- MACD
- CCRN 0.09
- SVRA -0.01
- Stochastic Oscillator
- CCRN 62.03
- SVRA 57.77
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.